SEC Form 4 · accession 0001209191-18-014304
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Andrew Sherman
Officer — EVP, GEN. COUN. & SECRTY
Period of report
Feb 26, 2018
Accepted (ET)
Feb 27, 2018 · 8:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Feb 26, 2018 | M | 10,000 | $30.49 | A | 57,566 | D | |
| Class A Common StockF1 | Feb 26, 2018 | S | 10,000 | $65.00 | D | 47,566 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $30.49 | Feb 26, 2018 | M | 10,000 | D | — | Dec 21, 2022 | Class A Common Stock | 10,000 | 12,919 | D |
Explanation of responses
- F1Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest.
- F2This option was granted for a total of 61,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
Remarks
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.